MD Anderson and CureVac announce a strategic collaboration to develop off-the-shelf mRNA-based cancer vaccines for select hematologic and solid tumors.

Read about it here: brnw.ch/21wIRth CureVac #EndCancer

The Technology in Cancer Research & Treatment journal team is looking for Associate Editors to support peer review and maintain our quality standards for publishing. Interested? Apply today: sagepub.checkboxonline.com/tcrt-associate…

Please share with your colleagues too!

#oncology …

One of Technology in Cancer Research & Treatment Journal's most read reviews from last year is a comprehensive review on the relationship between the immune system and head and neck cancer.
journals.sagepub.com/doi/10.1177/15…
#headandneckcancer awarenessmonth #headandneckcancer #openaccess #cancerresearch

Sage has an open access agreement specifically for Swedish institutions part of the Bibsam consortium!

Learn more and check if you qualify for the deal here: ow.ly/AtxH50QVuzs

SCI members @adamdelazerd, Yonatan Winetraub, Kavita Sarin, & others developed a noninvasive #VirtualBiopsy using micro-registered optical coherence tomography. bit.ly/3xA0JSb

Cancer patients can now be 'matched' to best treatment with DNA and lab-dish experiments

Identifying the most effective cancer treatment for a given patient from the get-go can help improve outcomes.

apple.news/ACdajl8MFRred1…

Have questions about publishing in Technology in Cancer Research & Treatment? Read more about the journal, including indexing and Article Processing Information, at the link below 👇 or email us at: [email protected]

journals.sagepub.com/description/TCT

#OpenAccess #CancerResearch

New article from Technology in Cancer Research & Treatment - Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma
Jian-Guo Zhou

journals.sagepub.com/doi/full/10.11…

#cancerresearch #biomarkers #cancerdiagnosis #OpenAccess

📢 Check out this #FLASH #radiotherapy collection open for submissions!
Lead Guest Editor: Hongying Feng, Mayo Clinic
Submission Deadline: Sep 23, 2024

journals.sagepub.com/topic/collecti…

#cancerresearch #protontherapy

Improved Molecular Classification Drives Tailored Treatment Approaches in Endometrial Cancer Sylvester Comprehensive Cancer Center #gyncsm #oncology onclive.com/view/improved-…

📢New Special Collection alert!
The Genetic Basis of Cancer in Underrepresented Populations
Junior Guest Editor: Waleed Al Amri, The Royal Hospital, Oman
Co-Guest Editor: Thomas A Hughes, York St John University, UK
Submission Deadline: September 26, 2024

journals.sagepub.com/topic/collecti……

📢New Special Collection alert!
Technologies in Cancer Health Disparities Research
Guest Editor: Dr. Kumaraswamy Naidu Chitrala University of Houston
Submission Deadline: October 4, 2024
journals.sagepub.com/page/tct/colle…

#healthdisparities #cancerresearch #bioinformatics #computationalbiology

Only saw a partial solar eclipse in California, but still amazing!!

#Eclipse 2024 #Eclipse #solareclipse

Enjoying all the coverage of #AACR24 !

AACR #CancerResearch

As a journal editor I am proud to support advances in research that improve quality of life, patient care, and outcomes.

#WorldHealthDay #WorldHealthDay 2024 #CancerResearch #OpenAccess #medicine #health

⭐️How can we expand the druggable targets across all tumors?
We need more drugs across all areas. Ben Cravatt Scripps Research talks about some of the opportunities & challenges AACR #aacr24 Cancer Discovery

Falcon 9 launch all the way up at Vandenberg. Great light right at sunset! 🌅 🚀

SpaceX #socal

⚡️Excited to see the surge of translational research on liquid biopsy at AACR #aacr24 🧪 Our latest article, 'Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)' published in Annals of Oncology Annals of Oncology ESMO - Eur. Oncology adds valuable insights to this evolving…